Author Archives for Adeline Chauvigné

OSE IMMUNOTHERAPEUTICS: 1ST PRIZE OF DELOITTE IN EXTENSO TECHNOLOGY FAST 50

OSE Immunotherapeutics, a biotechnology company, which is a member of the Atlanpole Biotherapies cluster and which develops immunotherapy for activation... View Article

CESTI IHU: TOWARDS NEW CELLULAR THERAPY APPROACHES IN TRANSPLANTATION

About characterizing regulatory populations to develop cell therapy approaches in transplantation. “The CESTI IHU has made it possible to strengthen... View Article

Rédigé par Adeline Chauvigné, le 2016-12-12

CESTI IHU: TOWARDS NEW CELLULAR THERAPY APPROACHES IN TRANSPLANTATION

About characterizing regulatory populations to develop cell therapy approaches in transplantation. “The CESTI IHU has made it possible to strengthen... View Article

IN CELL ART: TOWARDS INNOVATIVE VACCINES

The start-up company was founded in 2005, by a team of researchers including Jean-Marie Lehn, a Nobel laureate in chemistry... View Article

Rédigé par Adeline Chauvigné, le 2016-12-15

IN CELL ART: TOWARDS INNOVATIVE VACCINES

The start-up company was founded in 2005, by a team of researchers including Jean-Marie Lehn, a Nobel laureate in chemistry... View Article

A FIRST! THE AQUALEG PROSTHESIS REFERENCED AND REIMBURSED BY THE FRENCH SOCIAL INSURANCE

The innovative prosthesis wraps created by Aqualeg, a member of the Atlanpole Biotherapies cluster, have been included in the list... View Article

Rédigé par Adeline Chauvigné, le 2016-12-15

A FIRST! THE AQUALEG PROSTHESIS REFERENCED AND REIMBURSED BY THE FRENCH SOCIAL INSURANCE

The innovative prosthesis wraps created by Aqualeg, a member of the Atlanpole Biotherapies cluster, have been included in the list... View Article

Atlantic Bone Screen, a new website

Atlantic Bone Screen is pleased to present you its new website! New design, new content, new technology… it illustrates our... View Article

Rédigé par Adeline Chauvigné, le 2016-11-07

Atlantic Bone Screen, a new website

Atlantic Bone Screen is pleased to present you its new website! New design, new content, new technology… it illustrates our... View Article

GE Healthcare and Valneva : new delivery for Vaccine Production

GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production  + Collaboration jointly developed a new medium optimized... View Article

Florence Hallouin is appointed Deputy Director of Atlanpole Biotherapies Cluster

Florence HALLOUIN is appointed Deputy Director of Atlanpole Biotherapies.  She ensures the operational coordination of the Cluster, relationships with its partners... View Article

Rédigé par Adeline Chauvigné, le 2016-10-03

Florence Hallouin is appointed Deputy Director of Atlanpole Biotherapies Cluster

Florence HALLOUIN is appointed Deputy Director of Atlanpole Biotherapies.  She ensures the operational coordination of the Cluster, relationships with its partners... View Article

CESTI IHU: innovative strategies of tolerance induction in the transplanted patient

This research program, led by Dr. Sophie Conchon (CRTI – Inserm 1064 – ITUN) uses the specific immunological properties of... View Article

Rédigé par Adeline Chauvigné, le 2016-10-03

CESTI IHU: innovative strategies of tolerance induction in the transplanted patient

This research program, led by Dr. Sophie Conchon (CRTI – Inserm 1064 – ITUN) uses the specific immunological properties of... View Article

Affilogic signs with Takeda global pharma

Takeda and Affilogic entered into a research collaboration to develop therapies based on Nanofitines® in the central nervous system …... View Article

Rédigé par Adeline Chauvigné, le 2016-10-03

Affilogic signs with Takeda global pharma

Takeda and Affilogic entered into a research collaboration to develop therapies based on Nanofitines® in the central nervous system …... View Article

ARRONAX PLUS: NEW TOOLS TO ENRICH THE NUCLEAR ARSENAL AGAINST CANCER

   The objective in nuclear medicine (imaging and therapy) is to build up both a world-class research group and eventually... View Article

Rédigé par Adeline Chauvigné, le 2016-10-03

ARRONAX PLUS: NEW TOOLS TO ENRICH THE NUCLEAR ARSENAL AGAINST CANCER

   The objective in nuclear medicine (imaging and therapy) is to build up both a world-class research group and eventually... View Article